These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8453569)

  • 1. Prevention of human pancreatic cancer cell-induced hepatic metastasis in nude mice by dipyridamole and its analog RA-233.
    Tzanakakis GN; Agarwal KC; Vezeridis MP
    Cancer; 1993 Apr; 71(8):2466-71. PubMed ID: 8453569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiation of the antiplatelet action of adenosine in whole blood by dipyridamole or dilazep and the cAMP phosphodiesterase inhibitor, RA 233.
    Dawicki DD; Agarwal KC; Parks RE
    Thromb Res; 1986 Jul; 43(2):161-75. PubMed ID: 3016942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of antiplatelet agents alone or in combinations on platelet aggregation and on liver metastases from a human pancreatic adenocarcinoma in the nude mouse.
    Tzanakakis GN; Agarwal KC; Veronikis DK; Vezeridis MP
    J Surg Oncol; 1991 Sep; 48(1):45-50. PubMed ID: 1890839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of plasma adenosine in the antiplatelet action of HL 725, a potent inhibitor of cAMP phosphodiesterase: species differences.
    Agarwal KC; Buckley RS; Parks RE
    Thromb Res; 1987 Jul; 47(2):191-200. PubMed ID: 2821650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of hepatic metastasis from a human pancreatic adenocarcinoma (RWP-2) in the nude mouse by prostacyclin, forskolin, and ketoconazole.
    Tzanakakis GN; Agarwal KC; Vezeridis MP
    Cancer; 1990 Feb; 65(3):446-51. PubMed ID: 2404557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of adenosine uptake and metabolism by blood cells in the antiplatelet actions of dipyridamole, dilazep and nitrobenzylthioinosine.
    Dawicki DD; Agarwal KC; Parks RE
    Biochem Pharmacol; 1985 Nov; 34(22):3965-72. PubMed ID: 4062970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pyrimido-pyrimidine derivatives, dipyridamole, mopidamol and RA-642, prevent from retinal vascular defects in experimental diabetes mellitus.
    De La Cruz JP; Moreno A; Mérida F; García Campos J; Sánchez de la Cuesta F
    Thromb Res; 1996 Feb; 81(3):327-37. PubMed ID: 8928090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The preventive effect of ketoconazole on experimental metastasis from a human pancreatic carcinoma may be related to its effect on prostaglandin synthesis.
    Tzanakakis GN; Krambovitis E; Tsatsakis AM; Vezeridis MP
    Int J Gastrointest Cancer; 2002; 32(1):23-30. PubMed ID: 12630766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiplatelet effect of the pyrimido-pyrimidinic derivative RA-642.
    de la Cruz JP; Moron D; Sanchez de la Cuesta F
    Thromb Res; 1991 Aug; 63(4):463-8. PubMed ID: 1754999
    [No Abstract]   [Full Text] [Related]  

  • 10. Synergistic effect of cilostazol and dipyridamole mediated by adenosine on shear-induced platelet aggregation.
    Nakamura T; Uchiyama S; Yamazaki M; Iwata M
    Thromb Res; 2007; 119(4):511-6. PubMed ID: 17046050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Modification of metastasis formation by inhibition of platelet aggregation. Experimental and clinical results].
    Gastpar H
    Laryngol Rhinol Otol (Stuttg); 1983 Dec; 62(12):578-85. PubMed ID: 6369051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inhibitory effects of Forskolin on hepatic metastasis from human colon cancer in nude mice].
    Yoshizawa J; Yoshida K; Fujikawa T; Tanabe A; Sakurai K
    Nihon Geka Gakkai Zasshi; 1995 Jan; 96(1):26-30. PubMed ID: 7898427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymeric inhibitors of platelet aggregation. II. Copolymers of dipyridamole and related drugs with N-vinylpyrrolidone.
    Bamford CH; Middleton IP; Al-Lamee KG
    Biochim Biophys Acta; 1987 Apr; 924(1):38-44. PubMed ID: 3828396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dipyridamole inhibits platelet aggregation in whole blood.
    Gresele P; Zoja C; Deckmyn H; Arnout J; Vermylen J; Verstraete M
    Thromb Haemost; 1983 Dec; 50(4):852-6. PubMed ID: 6665766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of dipyridamole alone and in combination with aspirin on whole blood platelet aggregation, PGI2 generation, and red cell deformability ex vivo in man.
    Saniabadi AR; Fisher TC; McLaren M; Belch JF; Forbes CD
    Cardiovasc Res; 1991 Mar; 25(3):177-83. PubMed ID: 2029709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of combining three different antiplatelet agents on platelets and leukocytes in whole blood in vitro.
    Zhao L; Bath P; Heptinstall S
    Br J Pharmacol; 2001 Sep; 134(2):353-8. PubMed ID: 11564653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro effect of mopidamol on platelet-subendothelium interaction.
    De La Cruz JP; Villalobos MA; Palacios R; Smith-Agreda JM; Sánchez de la Cuesta F
    Thromb Res; 1995 Jan; 77(1):97-103. PubMed ID: 7701482
    [No Abstract]   [Full Text] [Related]  

  • 18. Inihibition of human platelet aggregation by dipyridamole and two related compounds and its modification by acid glycoproteins of human plasma.
    Niewiarowski S; Lukasiewicz H; Nath N; Tai Sha A
    J Lab Clin Med; 1975 Jul; 86(1):64-76. PubMed ID: 1151144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet aggregation inhibitors in the prevention of metastasis in neoplastic disease: a review of experimental and clinical investigations.
    Gastpar H; Ambrus JL; Ambrus CM
    J Med; 1981; 12(1):15-33. PubMed ID: 6943264
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on platelet aggregation in vivo. VI. Effect of a pyrimido-pyrimidine derivative [RA233] on tumor cell metastasis.
    Ambrus JL; Ambrus CM; Gastpar H
    J Med; 1978; 9(2):183-6. PubMed ID: 276567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.